180 related articles for article (PubMed ID: 12802286)
1. Molecular processes of chromosome 9p21 deletions in human cancers.
Sasaki S; Kitagawa Y; Sekido Y; Minna JD; Kuwano H; Yokota J; Kohno T
Oncogene; 2003 Jun; 22(24):3792-8. PubMed ID: 12802286
[TBL] [Abstract][Full Text] [Related]
2. Molecular processes of chromosome 9p21 deletions causing inactivation of the p16 tumor suppressor gene in human cancer: deduction from structural analysis of breakpoints for deletions.
Kohno T; Yokota J
DNA Repair (Amst); 2006 Sep; 5(9-10):1273-81. PubMed ID: 16931177
[TBL] [Abstract][Full Text] [Related]
3. Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells.
Florl AR; Schulz WA
Genes Chromosomes Cancer; 2003 Jun; 37(2):141-8. PubMed ID: 12696062
[TBL] [Abstract][Full Text] [Related]
4. Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.
Hamada K; Kohno T; Takahashi M; Yamazaki M; Yamazaki M; Tashiro H; Sugawara C; Ohwada S; Sekido Y; Minna JD; Yokota J
Genes Chromosomes Cancer; 2000 Mar; 27(3):308-18. PubMed ID: 10679921
[TBL] [Abstract][Full Text] [Related]
5. Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines.
Raschke S; Balz V; Efferth T; Schulz WA; Florl AR
Genes Chromosomes Cancer; 2005 Jan; 42(1):58-67. PubMed ID: 15495191
[TBL] [Abstract][Full Text] [Related]
6. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
[TBL] [Abstract][Full Text] [Related]
7. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
Sato M; Takahashi K; Nagayama K; Arai Y; Ito N; Okada M; Minna JD; Yokota J; Kohno T
Genes Chromosomes Cancer; 2005 Dec; 44(4):405-14. PubMed ID: 16114034
[TBL] [Abstract][Full Text] [Related]
8. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
[TBL] [Abstract][Full Text] [Related]
9. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA
Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361
[TBL] [Abstract][Full Text] [Related]
10. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
[TBL] [Abstract][Full Text] [Related]
11. Prevalent involvement of illegitimate V(D)J recombination in chromosome 9p21 deletions in lymphoid leukemia.
Kitagawa Y; Inoue K; Sasaki S; Hayashi Y; Matsuo Y; Lieber MR; Mizoguchi H; Yokota J; Kohno T
J Biol Chem; 2002 Nov; 277(48):46289-97. PubMed ID: 12228235
[TBL] [Abstract][Full Text] [Related]
12. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.
Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J
Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339
[TBL] [Abstract][Full Text] [Related]
13. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
14. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
[TBL] [Abstract][Full Text] [Related]
15. Probing the chromosome 9p21 region susceptible to DNA double-strand breaks in human cells in vivo by restriction enzyme transfer.
Sato M; Sasaki H; Kazui T; Yokota J; Kohno T
Oncogene; 2005 Sep; 24(40):6108-18. PubMed ID: 16007206
[TBL] [Abstract][Full Text] [Related]
16. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.
Pollock PM; Pearson JV; Hayward NK
Genes Chromosomes Cancer; 1996 Feb; 15(2):77-88. PubMed ID: 8834170
[TBL] [Abstract][Full Text] [Related]
17. Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
Stadler WM; Sherman J; Bohlander SK; Roulston D; Dreyling M; Rukstalis D; Olopade OI
Cancer Res; 1994 Apr; 54(8):2060-3. PubMed ID: 7513608
[TBL] [Abstract][Full Text] [Related]
18. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
[TBL] [Abstract][Full Text] [Related]
19. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
[TBL] [Abstract][Full Text] [Related]
20. Mapping a putative tumor suppressor gene on chromosome 9 bands p21-p22 with microdissection probes.
Bohlander SK; Dreyling MH; Hagos F; Sveen L; Olopade OI; Díaz MO
Genomics; 1994 Nov; 24(2):211-7. PubMed ID: 7535286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
